KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Common Equity (2019 - 2025)

Hims & Hers Health's Common Equity history spans 7 years, with the latest figure at $540.9 million for Q4 2025.

  • For Q4 2025, Common Equity rose 13.47% year-over-year to $540.9 million; the TTM value through Dec 2025 reached $540.9 million, up 13.47%, while the annual FY2025 figure was $540.9 million, 13.47% up from the prior year.
  • Common Equity for Q4 2025 was $540.9 million at Hims & Hers Health, down from $581.0 million in the prior quarter.
  • Across five years, Common Equity topped out at $581.0 million in Q3 2025 and bottomed at $292.5 million in Q1 2021.
  • The 5-year median for Common Equity is $334.6 million (2021), against an average of $382.5 million.
  • The largest annual shift saw Common Equity soared 347.77% in 2021 before it fell 12.45% in 2022.
  • A 5-year view of Common Equity shows it stood at $334.6 million in 2021, then dropped by 6.84% to $311.7 million in 2022, then increased by 10.36% to $344.0 million in 2023, then soared by 38.57% to $476.7 million in 2024, then grew by 13.47% to $540.9 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Common Equity are $540.9 million (Q4 2025), $581.0 million (Q3 2025), and $562.7 million (Q2 2025).